Neurocutaneous Melanosis Associated With Malignant Leptomeningeal Melanoma in an Adult: Clinical Significance of 5-S-Cysteinyldopa in the Cerebrospinal Fluid -Case Report-
Authors:
Open Access
- 1 January 2003
- journal article
- case report
- Published by Japan Neurosurgical Society in Neurologia medico-chirurgica
- Vol. 43 (12) , 619-625
Abstract
A 35-year-old male presented with a variant of neurocutaneous melanosis with leptomeningeal malignant melanoma. He had three pigmented nevi from birth. He suffered diplopia followed by headache. T1-weighted magnetic resonance (MR) imaging revealed hydrocephalus and a small linear hyperintense lesion in the right frontal cortex. Several parts of the cortical sulci and the brain surface were slightly enhanced by gadolinium. Ventriculoperitoneal shunting was performed and extensive pigmented leptomeninges were recognized. Open biopsy established the diagnosis of leptomeningeal malignant melanoma. Combined chemoimmunotherapy was repeated every other month with monitoring of the 5-S-cysteinyldopa (5-S-CD) level in the cerebrospinal fluid (CSF). The 5-S-CD level decreased after each treatment, but the basal level steadily increased prior to the next treatment. Two years after the onset, he showed paraplegia caused by an extramedullary mass at the T-6 level. MR imaging showed that melanoma had involved the entire subarachnoid space including the whole spine. He underwent emergent removal of the spinal tumor and showed transient marked improvement. Further intensive chemotherapy was given. However, he died 31 months after the onset of massive proliferation of intracranial leptomeningeal melanoma. Measurement of CSF 5-S-CD levels is valuable for evaluating the therapeutic efficacy and for monitoring the progression of melanoma.Keywords
This publication has 20 references indexed in Scilit:
- Primary Leptomeningeal MelanomaNeurosurgery, 1993
- Neurocutaneous melanosis: Definition and review of the literatureJournal of the American Academy of Dermatology, 1991
- Long-term survival after removal of primary intracranial malignant melanomaActa Neurochirurgica, 1989
- Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjectsJournal of the American Academy of Dermatology, 1988
- Neurocutaneous melanosis with extensive intracerebral and spinal cord involvementJournal of Neurosurgery, 1984
- Melanosis and hydrocephalusJournal of Neurosurgery, 1984
- Analysis of cysteinyldopas, dopa, dopamine, noradrenaline and adrenaline in serum and urine using high-performance liquid chromatography and electrochemical detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1979
- Neurocutaneous Melanosis With Malignant Leptomeningeal MelanomaArchives of Neurology, 1975
- Primary Malignant Leptomeningeal Melanoma in Association with Giant Hairy NeviJournal of Neurosurgery, 1967
- Giant Pigmented Nevi, Melanoma, and Leptomeningeal MelanocytosisArchives of Dermatology, 1965